Nemera is one of the world leaders in the design, development and manufacturing of drug delivery solutions. Its expertise covers all five modes of delivery:
Nemera provides solutions for the pharmaceutical, biotechnology and generics industries, including standard innovative products ("off-the-shelf") and development of custom devices and contract manufacturing. Innovating for patients is at the core of Nemera's mission. More than 50 engineers and experts work to achieve this at the Innovation Centre at La Verpillière, near Lyon, France.
Preservatives have been shown to be harmful to the eye and can lead patients to discontinue or skip treatment to avoid irritation and discomfort.
The new preservative-free multidose ophthalmic packaging Novelia® avoids the need for preservatives in the drug by preventing contamination of unpreserved formulations.
Novelia has been well accepted by patients in over 15 countries worldwide, including the US, and European, Latin American and Asian nations. It is used as for packaging drug products as well as medical devices. As of today, Novelia is the only preservative-free multidose system commercialised on the US market.
Nemera offers an extensive range of metered pumps and valves, compatible with a wide choice of actuators in different shapes and fitments for nasal, buccal and auricular delivery.
Following the SP270, a standard spray pump for ear, nose and throat, SP270+ is the new optimized pump engine in terms of performance and raw materials.
Also, Advancia is a new breed of pharmaceutical pump combining user-independence and preservative-free features in one single system. Advancia offers a new alternative to improve treatment compliance in an increasingly demanding nasal spray market. The Advancia pump technology platform has been completely designed by Nemera to meet regulatory expectations and offer patients a user-friendly nasal spray.
The Advancia innovative project is cofinanced by the EU. Europe is committed in Normandy with the European Regional Development Fund (ERDF).
Nemera leverages decades of manufacturing and development experience in parenteral complex devices moulding and assembly such as safety devices, pens, autoinjectors and implanters.
Nemera's Safe'n'Sound® is a fully passive safety device for prefilled syringes to aid in the protection of healthcare professionals, patients who self-inject doctor prescribed medications, and individuals that assist self-injecting patients, from accidental needle sticks.
Nemera offers dermal delivery devices for OTC and prescription drugs that are recognised and appreciated by patients today.
Nemera's airless systems, pumps and valves are designed to handle a variety of formulations with different viscosities. We have extensive expertise in airless delivery systems that dispense and protect very sensitive products.
Key players in the pharmaceutical industry have trusted Nemera to develop and industrialise pulmonary devices for strategic products. Consistency and reliability are critical for respiratory patients. Nemera has a recognised expertise in the development and manufacturing of respiratory drug delivery devices, such as dry powder inhalers (DPIs), pressurised metered dose inhalers (pMDIs) and dose counters. In particular, Inhalia is a new generation of valve for pMDIs.